1. Home
  2. VYGR vs FVCB Comparison

VYGR vs FVCB Comparison

Compare VYGR & FVCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Voyager Therapeutics Inc.

VYGR

Voyager Therapeutics Inc.

HOLD

Current Price

$3.76

Market Cap

194.0M

Sector

Health Care

ML Signal

HOLD

Logo FVCBankcorp Inc.

FVCB

FVCBankcorp Inc.

HOLD

Current Price

$14.50

Market Cap

229.7M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
VYGR
FVCB
Founded
2013
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
194.0M
229.7M
IPO Year
2015
2018

Fundamental Metrics

Financial Performance
Metric
VYGR
FVCB
Price
$3.76
$14.50
Analyst Decision
Strong Buy
Buy
Analyst Count
3
1
Target Price
$21.00
$18.00
AVG Volume (30 Days)
837.1K
48.2K
Earning Date
03-09-2026
04-21-2026
Dividend Yield
N/A
1.66%
EPS Growth
N/A
47.56
EPS
N/A
1.21
Revenue
$10,135,000.00
$1,781,000.00
Revenue This Year
$54.19
$18.73
Revenue Next Year
$20.22
$7.99
P/E Ratio
N/A
$11.98
Revenue Growth
N/A
13.87
52 Week Low
$2.65
$9.49
52 Week High
$5.55
$16.35

Technical Indicators

Market Signals
Indicator
VYGR
FVCB
Relative Strength Index (RSI) 43.57 36.28
Support Level $3.60 $13.09
Resistance Level $4.43 $15.40
Average True Range (ATR) 0.33 0.41
MACD -0.03 -0.10
Stochastic Oscillator 4.37 13.42

Price Performance

Historical Comparison
VYGR
FVCB

About VYGR Voyager Therapeutics Inc.

Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.

About FVCB FVCBankcorp Inc.

FVCBankcorp Inc is a registered bank holding company. It operates through the sole subsidiary, FVCbank which is a community-oriented, locally-owned, and managed commercial bank. It offers commercial banking services to small and medium-sized businesses, professionals, non-profit organizations and associations, and investors. It also provides retail banking services to accommodate the individual needs of both corporate customers as well as the communities it serves. The bank provides other facilities such as online banking, mobile banking, remote deposit service, and lending products, among others. Its primary source of revenue is the net interest income.

Share on Social Networks: